No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Entero Therapeutics | 10-K/A: Annual report (Amendment)
Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
Entero Therapeutics | 10-K: FY2024 Annual Report
Entero Therapeutics Announces Signing of Rescission Agreement With ImmunogenX, LLC
12 Health Care Stocks Moving In Monday's After-Market Session
Vicarious Surgical Names Sarah Romano Finance Chief